FDA Approved: CIMDUO — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved a supplemental application for Cimduo (lamivudine and tenofovir disoproxil fumarate) submitted by Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• CIMDUO (LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

SUPPL AP for CIMDUO (LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE)